Moderna aims to roll out a combined COVID-flu-RSV booster vaccine in late 2023, the US pharmaceutical firm says, hoping a joint shot will encourage people to get an annual vaccination.
The single vaccine for COVID-19, influenza and respiratory syncytial virus — a common virus that causes the cold, but can be more serious for infants and elderly people — could appear on the market before 2024.
“Best-case scenario will be the fall of ’23,” Moderna chief executive Stephane Bancel tells a virtual World Economic Forum roundtable session.
“I don’t think it would happen in every country, but we believe it’s possible to happen in some countries next year. Our goal is to be able to have a single annual booster so that we don’t have compliance issues where people don’t want to get two to three shots a winter, but to get one dose.”
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
— Gabriella Jacobs, multimedia journalist
Support our work
Support our work
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
From the Liveblog of
Monday, January 17, 2022
Add ToI as a Preferred Source on Google
